- $28.57m
- $29.30m
- $1.27m
Brief: IGC Announces Issuance Of Patent For Treatment Of Alzheimer's Disease Using THC
India Globalization Capital soars on Alzheimer's drug trial update
Brief: IGC Completes The Final Cohort Of Its Phase 1 Clinical Trial On Alzheimer's Patients
Brief: IGC Completes Cohort 2 Of Its Phase 1 THC-Based Clinical Trial On Alzheimer's Patients
Brief: India Globalization Capital Completes Cohort 1 Of Phase 1 THC-Based Clinical Trial
Brief: Update On Igc’S Phase 1 Clinical Trial On Alzheimer’S Patients
Brief: India Globalization Capital Files For Mixed Shelf Offering Of Up To $100 Mln - SEC Filing
Brief: India Globalization Capital Inc - Enrolling Participants Suffering From Mild To Severe Dementia Due To Alzheimer's Disease For Its Phase 1 Clinical Trial
Brief: IGC Reports Qtrly Loss Per Share Of $0.05
AMEX RESUMED INDIA GLOBLZN CP
AMEX HALT ADDITIONAL INFORMATION LAST 2.270000
AMEX RESUMED INDIA GLOBLZN CP
AMEX HALT ADDITIONAL INFORMATION LAST 2.420000
AMEX RESUMED INDIA GLOBLZN CP
AMEX HALT ADDITIONAL INFORMATION LAST 1.970000
AMEX RESUMED INDIA GLOBLZN CP
AMEX HALT ADDITIONAL INFORMATION LAST 2.220000
AMEX RESUMED INDIA GLOBLZN CP
AMEX HALT ADDITIONAL INFORMATION LAST 2.360000